Asset
ALDUMASTAT
Lakefront Biotherapeutics American Depositary Shares
Revenue
No revenue reported in loaded filings.
Clinical trials (3)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT03595618 | phase2 | completed | 2018-08-14 | 2020-07-14 | Lakefront Biotherapeutics NV | A Study to Assess Efficacy and Safety of GLPG1972/S201086 in Participants With Knee Osteoarthritis |
| NCT02851485 | phase1 | completed | 2016-07-01 | 2016-07-01 | Lakefront Biotherapeutics NV | Bioavailability Study With GLPG1972 |
| NCT03143725 | phase1 | completed | 2017-04-14 | 2017-06-06 | Lakefront Biotherapeutics NV | Study to Compare Bioavailability of GLPG1972 Given as 2 Different Tablet Formulations Versus an Oral Solution |
FDA applications (0)
This company has no applications containing this asset.